ATH 33.3% 0.4¢ alterity therapeutics limited

... so sorry, page-42

  1. 3,401 Posts.
    lightbulb Created with Sketch. 72
    Our best bet is showing slowed rate of decline in the extension patients against normative data. If there is no difference then toss it.The subjects are still on it whether for hope or due to their own perception,must be a reason. this semi longitudinal view may give big pharmacy a sniff of potential.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.